Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...

NeuroEM Therapeutics®, an award-winning clinical-stage biotechnology research company pioneering the use of radio frequencies ...

Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program - ...

The Bulletin of the Atomic Scientists said the clock could be turned back if leaders and nations worked together to address ...

Court said CBI was trying to bypass interrogation & investigation process by asking accused for what amounted to a statement.

NINGBO, ZHEJIANG PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- In recent years, the global life science ...

We’re hoping to see more early-stage funding in 2026 to help newer companies get off the ground. The public market, especially IPOs, has been a bit slow, with only 11 companies going public in 2025, ...

Uganda is one of the countries in Africa that continue to lose opportunities to overcome challenging agricultural production ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

In a detailed judgment, the apex court found that the high court had proceeded on “erroneous assumptions” regarding land use, ...